Promedius Inc. announced that it has received KRW 21,500 million in a round of funding on June 5, 2026. The transaction included participation from existing investors, STASSETS Investment, Woori Venture Partners Co., Ltd, new investors, Kolon Investment, Inc., SL Investment, Quad Asset Management Lp, Daewoong Pharmaceutical Co., Ltd, NAVER Corporation, Industrial Bank of Korea, Heungkuk Securities Co., Ltd, Yukyung PSG Asset Management. The company has issued convertible preferred shares in the transaction.

The company has raised KRW 35,000 million in funding till date.

Add MarketScreener to your sources

Stocks mentioned in the article

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Off-Hours Price	Change	5-day change	Capi.
WOORI VENTURE PARTNERS CO., LTD	2,555.00KRW	-.--%	-.--%	197M
NAVER CORPORATION	190,000.00KRW	+0.21%	-0.68%	19.12B
INDUSTRIAL BANK OF KOREA	21,600.00KRW	+1.65%	+1.65%	11.58B
DAEWOONG PHARMACEUTICAL CO., LTD	121,900.00KRW	+2.52%	-7.58%	943M

Latest news about Woori Venture Partners Co., Ltd

07-12	ARKGENBIOSCIONS Inc. announced that it has received KRW 10 billion in funding from a group of investors	CI
07-12	ARKGENBIOSCIONS Inc. announced that it expects to receive KRW 999.96 million in funding from a group of investors	CI
06-04	Promedius Inc. announced that it has received KRW 21.5 billion in funding from a group of investors	CI
05-31	Unastella Corporation announced that it has received KRW 33.5 billion in funding from Strong Ventures, LLC, Hana Ventures Inc., Altos Ventures Management, Inc., Korea Development Bank, Samho Green Investment, Inc., KDB Capital Corp., Woori Venture Partners Co., Ltd and other investors	CI
05-26	UBASE INC. acquired ReturnZero Inc. from a group of shareholders.	CI
04-29	Upstage Co., Ltd. announced that it expects to receive KRW 560 billion in funding from SK Networks Company Limited, Korea Development Bank, Investment Arm, KDB Investment Co., Ltd., Mirae Asset Venture Investment Co., Ltd., Sazze Partners, Inc., Woori Venture Partners Co., Ltd	CI
04-15	Upstage Co., Ltd. announced that it expects to receive funding from a group of investors	CI
03-15	Inventage Lab, Inc. announced that it has received KRW 89.99724455 billion in funding from a group of investors	CI
03-05	Inventage Lab, Inc. announced that it expects to receive KRW 37.25 billion in funding from a group of investors	CI
03-05	Inventage Lab, Inc. announced that it expects to receive KRW 52.74724455 billion in funding from a group of investors	CI
03-04	Beijing Robot Era Technology Co., Ltd. announced that it has received CNY 1 billion in funding from a group of investors	CI
02-25	GenEdit Inc. announced that it has received $60 million in funding from a group of investors	CI
02-22	BOS Semiconductors Co.,Ltd. announced that it has received KRW 87 billion in funding from a group of investors	CI
01-15	Orum Therapeutics, Inc. announced that it has received KRW 24.999873175 billion in funding from a group of investors	CI
12-23	Gfi Co., Ltd completed the acquisition of Daishin Balance No.18 Special Purpose Acquisition Co., Ltd. from Withers Invest Co., Ltd, Woori Venture Partners Co., Ltd and others in a reverse merger transaction.	CI

Chart Woori Venture Partners Co., Ltd

Duration

Period

A298870: Dynamic Chart

Company Profile

Woori Venture Partners Co Ltd, formerly Daol Investment Co Ltd, is a Korea-based company primarily engaged in venture capital business. The Company primarily engaged in the investment of in small and medium-sized enterprises. The Company is primarily engaged in the business of helping companies continuously build teams, design business models, prepare for initial public offering (IPO), consider private placements and others.

Employees

Sector

Investment Management & Fund Operators

More about the company